Picture EBD Group BIO-Europe 2021 Digital BEU2021 650x80
Organisation › Details

Expression Pathology Inc. (EPI)

Expression Pathology is advancing personalized medicine with assays that measure cancer signaling networks—at the functional protein level—in FFPE tissue to individualize and improve patient treatment decisions. Expression Pathology's patented Liquid Tissue®-SRM technology platform makes possible highly multiplexed protein quantitation by powerful mass spectrometry of minute amounts of laser microdissected FFPE tissue. Expression Pathology offers a broad menu of multiplexed SRM assays for major cancer signaling networks to advance development of targeted therapies and improve patient stratification. The assays include a range of drug target pathway proteins including EFGR, IGF-1R, cMET, Her3, cSRC, MEK, and their phosphorylation states, as well as many others. *


Period Start 2003-07-11 existent
Period End 2012-06-01 renamed before
  Group OncoPlex Diagnostics (OncoPlexDx)
  Today OncoPlex Diagnostics (OncoPlexDx)
  Successor OncoPlex Diagnostics (OncoPlexDx)
Products Industry tissue microarray
  Industry 2 cancer test
Region Region Rockville, MD
  Country United States (USA)
  Street 9620 Medical Center Drive
Suite 100
  City 20850 Rockville, MD
  Tel +1-301-977-3654
    Address record changed: 2020-12-02
Basic data Employees n. a.
    * Document for �About Section�: 
Record changed: 2018-10-31


Picture Berlin Partner Berlin-Brandenburg Healthcare Industries Cluster 650x80px

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture Demy-Colton BioFuture 2021 NYC D Meet Top Investors 650x300px

» top